A preparation method of medical wastewater treatment agent
By doping urea with titanium dioxide to form a modified photocatalyst and compounding it with composite aerogel and zeolite, a medical wastewater treatment agent with flocculation, photocatalysis and adsorption are prepared, which solves the difficulty of removing a single treatment agent in the prior art. The problems of heavy metal ions, organic pollutants and phosphorus-containing compounds have achieved efficient wastewater purification.
Patent Information
- Application Number
- CN202410780775.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-18
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-06-18
AI Technical Summary
In the existing medical wastewater treatment technology, it is difficult for a single treatment agent to effectively remove heavy metal ions, organic pollutants and phosphorus-containing compounds in the wastewater, and cannot meet emission standards.
Using a preparation method of medical wastewater treatment agent, by mixing urea and acetic acid and doping it with titanium dioxide, a modified photocatalyst is formed, and combined with composite aerogel, zeolite and sodium hypochlorite, forming flocculation, photocatalysis and adsorption effects. treatment agent.
The removal rate of metal ions, organic pollutants and phosphorus-containing compounds in wastewater is improved, and a more efficient wastewater purification effect is achieved.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of wastewater treatment, and in particular to a method for preparing a medical wastewater treatment agent. Background Art
[0002] In recent years, with the improvement of people's awareness of environmental protection, the wastewater generated by industries such as industry, medical treatment, papermaking and metallurgy contains a large amount of heavy metal ions, organic pollutants (toluene, formaldehyde, ethyl acetate, etc.), phosphorus compounds and other pollutants. After these pollutants are discharged into the natural environment, they will cause serious pollution to the environment. Among them, the rapid development of the medical industry has led to the generation of more and more medical wastewater. Medical wastewater treatment technologies include physical processes (flotation, coagulation and sedimentation), chemical processes (chemical oxidation, catalytic oxidation, etc.), biological treatment technologies and unconventional treatment technologies. Chemical treatment is one of the most commonly used methods and is widely used in wastewater treatment, and has excellent purification effects. Commonly used treatment agents in chemical treatment include flocculants, adsorbents, catalysts and other materials, but using only a single treatment agent to purify wastewater does not meet the discharge standards. Therefore, researchers need to develop a wastewater treatment agent with good comprehensive performance to purify pollutants in wastewater. Summary of the invention
[0003] In order to solve the above technical problems, the present invention provides a method for preparing a medical wastewater treatment agent.
[0004] The purpose of the present invention can be achieved through the following technical solutions:
[0005] A method for preparing a medical wastewater treatment agent comprises the following steps:
[0006] Step S1: urea and acetic acid are mixed in a beaker to form a mixed solution 1; titanium dioxide is then dispersed evenly in deionized water, the mixed solution 1 and nickel chloride hexahydrate are added and stirred to mix evenly, and finally ethanol is added, the temperature is raised to 25-45° C., ultrasonic treatment is performed for 30 minutes, the pH is adjusted to 3-7, and then the mixture is transferred to a hydrothermal reactor, and the mixture is hydrothermally reacted at 160-180° C. for 4-8 hours. After the reaction is completed, the mixture is centrifuged, washed, and dried to obtain N / Ni-TiO 2 Nanomaterials;
[0007] Step S2: N / Ni-TiO 2 The nanomaterial and 1,6-bistrimethoxysilylhexane are added to a mixture containing ethanol and deionized water, stirred and mixed evenly, and ultrasonically dispersed for 30 minutes, and then the nano-montmorillonite dispersion is added, and the system temperature is increased to 40-50° C. and stirred for reaction for 3-5 hours. After the reaction is completed, the modified photocatalyst is obtained;
[0008] Step S3: weighing raw materials by weight, stirring and mixing 12-20 parts of polyacrylamide, 10-15 parts of polyethyleneimine, 10-15 parts of composite aerogel, 5-8 parts of zeolite, 3-6 parts of modified photocatalyst and 0.5-3 parts of sodium hypochlorite to obtain a medical wastewater treatment agent;
[0009] Further, in step S1, the dosage ratio of titanium dioxide, deionized water, mixed solution 1, nickel chloride hexahydrate and ethanol is 1 mol: 20 mL: 25 mL: 0.005-0.01 mol: 20 mL, and the dosage ratio of urea and acetic acid in mixed solution 1 is 0.01-0.03 mol: 25 mL;
[0010] Furthermore, in step S2, N / Ni-TiO 2 The dosage ratio of nanomaterial, 1,6-bistrimethoxysilylhexane, ethanol, deionized water and nano-montmorillonite is 2-3g: 0.1-0.8mL: 80mL: 20mL: 10mL. The nano-montmorillonite dispersion is obtained by mixing nano-montmorillonite and deionized water in a dosage ratio of 0.5-1g: 10mL and then ultrasonically dispersing for 2h.
[0011] The composite aerogel is prepared by the following steps:
[0012] Step A1: dispersing halloysite nanotubes in a mixture of ethanol and deionized water, ultrasonically dispersing for 30 minutes, adding mercaptopropyltrimethoxysilane, and reflux reacting for 18-24 hours under nitrogen conditions. After the reaction is completed, washing and drying are performed to obtain mercaptolated halloysite;
[0013] Step A2: Add γ-aminopropyltriethoxysilane, 4-trimethoxysilylbutyric acid and ethyl orthosilicate into a flask containing deionized water and stir to mix evenly, then add ammonia water and stir for 8-12 hours. After the reaction is completed, filter, wash and freeze-dry to obtain bifunctional silica;
[0014] Step A3: Disperse bifunctional silica and chitosan in deionized water, add thiolated halloysite solution, stir and mix for 10 minutes, ultrasonically disperse for 30 minutes, then add gluconolactone solution under vigorous stirring to form a mixed solution, pour the mixed solution into a mold and let stand for 30-50 minutes to form a gel, and then freeze-dry the gel at -60°C for 48 hours to obtain a composite aerogel;
[0015] Further, in step A1, the usage ratio of halloysite nanotubes, ethanol, deionized water and mercaptopropyltrimethoxysilane is 1-2 g: 90 mL: 10 mL: 1.2-2.2 g;
[0016] Further, in step A2, the usage ratio of γ-aminopropyltriethoxysilane, 4-trimethoxysilylbutyric acid, ethyl orthosilicate, deionized water and ammonia water is 0.01-0.02 mol: 0.005-0.015 mol: 0.02 mol: 100 mL: 0.1-0.16 mL;
[0017] Further, in step A3, the dosage ratio of bifunctional silica, chitosan, deionized water, thiolated halloysite solution and gluconolactone solution is 0.2-0.5 g: 0.5-0.9 g: 50 mL: 10 mL: 10 mL;
[0018] Furthermore, in step A3, the thiolated halloysite solution is prepared by mixing thiolated halloysite and deionized water in a ratio of 0.05-0.09 g:10 mL, and the gluconolactone solution is prepared by mixing gluconolactone and deionized water in a ratio of 0.3-0.6 g:10 mL.
[0019] Beneficial effects of the present invention:
[0020] The medical wastewater treatment agent prepared by the invention uses polyacrylamide and polyethyleneimine with flocculation effect as main treatment agents, and is compounded by adding a modified photocatalyst with photocatalytic effect, a composite aerogel with adsorption effect, zeolite and sodium hypochlorite, thereby generating a synergistic effect and improving the wastewater treatment capacity.
[0021] In the modified photocatalyst, urea was used as the nitrogen source and nickel chloride hexahydrate was used as the nickel source to dope titanium dioxide, which improved the photocatalytic activity of silicon dioxide. This is because the doping of N and Ni elements can improve the photocatalytic activity of TiO 2 The separation efficiency of photogenerated carriers in the catalyst is improved, and the carrier transmission time is correspondingly prolonged, which increases the lifetime of photogenerated charges and promotes its photocatalytic activity. Then, a silane coupling agent is used to couple N / Ni-TiO 2 The composite of nanomaterials and nano-montmorillonite improves the photoactivity of the photocatalyst. This is because the water molecules and hydroxyl groups rich in the interlayer and surface of the nano-montmorillonite can react with h + The reaction further promotes the production of ·OH, effectively improving the activity of the photocatalyst, and ·OH can oxidize organic pollutants such as formaldehyde and toluene in the wastewater.
[0022] In the composite aerogel, firstly, thiolated halloysite is synthesized by condensation reaction between abundant hydroxyl groups on the surface of halloysite nanotubes and silanol groups produced by hydrolysis of silane coupling agent; secondly, bifunctional silica is synthesized using γ-aminopropyltriethoxysilane, 4-trimethoxysilylbutyric acid and ethyl orthosilicate as silicon sources; finally, composite aerogel is synthesized using thiolated halloysite, bifunctional silica and chitosan as raw materials. Composite aerogel is made of silicon dioxide as the main synthetic material, which is then compounded with halloysite and chitosan. The three-dimensional porous structure formed by it has the properties of each raw material itself, and has the advantages of large specific surface area, high porosity, and more surfactants of aerogel. Therefore, after introducing it into the matrix, the adsorption effect of the matrix on pollutants such as metal ions, organic pollutants, and phosphorus-containing compounds in medical wastewater is improved; among them, halloysite nanotubes have a large specific surface area and excellent adsorption, and can effectively adsorb and fix heavy metal ions, antibiotics, volatile organic compounds, etc. in wastewater. At the same time, the surface-modified thiol groups can also chelate the wastewater. The metal ions are further fixed on the surface of halloysite, further improving the wastewater treatment capacity of the matrix; the active groups such as amino and carboxyl contained in the bifunctional silica can effectively improve the wettability of the composite aerogel in aqueous solution, improve its adaptability in wastewater, and further improve the wastewater treatment effect of the matrix; the presence of chitosan further improves the wastewater treatment effect, because the amide and amino groups contained in the chitosan molecules are protonated in the wastewater, and then exhibit the role of cationic electrolytes, which adsorb pollutants in the wastewater through electrostatic action, complexation, etc., and then produce flocculation, thereby achieving the effect of purifying the wastewater. DETAILED DESCRIPTION
[0023] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. Embodiment 1
[0024] The composite aerogel is prepared by the following steps:
[0025] Step A1: 1 g of halloysite nanotubes was dispersed in a mixture of 90 mL of ethanol and 10 mL of deionized water, and ultrasonically dispersed for 30 min, and then 1.2 g of mercaptopropyltrimethoxysilane was added, and refluxed for 18 h under nitrogen conditions. After the reaction was completed, the mixture was washed and dried to obtain mercaptolated halloysite;
[0026] Step A2: 0.01 mol of γ-aminopropyltriethoxysilane, 0.005 mol of 4-trimethoxysilylbutyric acid and 0.02 mol of ethyl orthosilicate were added into a flask containing 100 mL of deionized water and stirred to mix evenly, and then 0.1 mL of ammonia water was added and stirred for 8 h. After the reaction was completed, the mixture was filtered, washed and freeze-dried to obtain bifunctional silica;
[0027] Step A3: 0.2 g of bifunctional silica and 0.5 g of chitosan were dispersed in 50 mL of deionized water, and 10 mL of thiolated halloysite solution was added, stirred and mixed for 10 min, ultrasonically dispersed for 30 min, and then 10 mL of gluconolactone solution was added under vigorous stirring to form a mixed solution, and then the mixed solution was poured into a mold and allowed to stand for 30 min to form a gel, and then the gel was freeze-dried at -60°C for 48 h to obtain a composite aerogel, the thiolated halloysite solution was prepared by mixing thiolated halloysite and deionized water in a dosage ratio of 0.05 g:10 mL, and the gluconolactone solution was prepared by mixing gluconolactone and deionized water in a dosage ratio of 0.3 g:10 mL. Embodiment 2
[0028] The composite aerogel is prepared by the following steps:
[0029] Step A1: 1.5 g of halloysite nanotubes were dispersed in a mixture of 90 mL of ethanol and 10 mL of deionized water, and ultrasonically dispersed for 30 min, and then 1.7 g of mercaptopropyltrimethoxysilane was added, and refluxed for 21 h under nitrogen conditions. After the reaction was completed, the mixture was washed and dried to obtain mercaptolated halloysite;
[0030] Step A2: 0.015 mol of γ-aminopropyltriethoxysilane, 0.01 mol of 4-trimethoxysilylbutyric acid and 0.02 mol of ethyl orthosilicate were added into a flask containing 100 mL of deionized water and stirred to mix evenly, and then 0.13 mL of ammonia water was added and stirred for 10 h. After the reaction was completed, the mixture was filtered, washed and freeze-dried to obtain bifunctional silica;
[0031] Step A3: 0.35 g of bifunctional silica and 0.7 g of chitosan were dispersed in 50 mL of deionized water, and 10 mL of thiolated halloysite solution was added, stirred for 10 min, ultrasonically dispersed for 30 min, and then 10 mL of gluconolactone solution was added under vigorous stirring to form a mixed solution, and then the mixed solution was poured into a mold and allowed to stand for 40 min to form a gel, and then the gel was freeze-dried at -60°C for 48 h to obtain a composite aerogel, the thiolated halloysite solution was prepared by mixing thiolated halloysite and deionized water in a dosage ratio of 0.07 g:10 mL, and the gluconolactone solution was prepared by mixing gluconolactone and deionized water in a dosage ratio of 0.45 g:10 mL. Embodiment 3
[0032] The composite aerogel is prepared by the following steps:
[0033] Step A1: 2 g of halloysite nanotubes are dispersed in a mixture of 90 mL of ethanol and 10 mL of deionized water, and ultrasonically dispersed for 30 min, and then 2.2 g of mercaptopropyltrimethoxysilane is added, and refluxed under nitrogen for 18-24 h. After the reaction is completed, the mixture is washed and dried to obtain mercaptolated halloysite;
[0034] Step A2: 0.02 mol of γ-aminopropyltriethoxysilane, 0.015 mol of 4-trimethoxysilylbutyric acid and 0.02 mol of ethyl orthosilicate were added into a flask containing 100 mL of deionized water and stirred to mix evenly, and then 0.16 mL of ammonia water was added and stirred for 12 h. After the reaction was completed, the mixture was filtered, washed and freeze-dried to obtain bifunctional silica;
[0035] Step A3: 0.5 g of bifunctional silica and 0.9 g of chitosan were dispersed in 50 mL of deionized water, and 10 mL of thiolated halloysite solution was added, stirred for 10 min, ultrasonically dispersed for 30 min, and then 10 mL of gluconolactone solution was added under vigorous stirring to form a mixed solution, and then the mixed solution was poured into a mold and allowed to stand for 50 min to form a gel, and then the gel was freeze-dried at -60°C for 48 h to obtain a composite aerogel, the thiolated halloysite solution was prepared by mixing thiolated halloysite and deionized water in a dosage ratio of 0.09 g:10 mL, and the gluconolactone solution was prepared by mixing gluconolactone and deionized water in a dosage ratio of 0.6 g:10 mL. Embodiment 4
[0036] A method for preparing a medical wastewater treatment agent comprises the following steps:
[0037] Step S1: 0.01 mol urea and 25 mL acetic acid were mixed in a beaker to form a mixed solution 1; 1 mol titanium dioxide was evenly dispersed in 20 mL deionized water, 25 mL of the mixed solution 1 and 0.005 mol nickel chloride hexahydrate were added and stirred to mix evenly, and finally 20 mL ethanol was added, the temperature was raised to 25°C and ultrasonic treatment was performed for 30 min, and the pH was adjusted to 3, and then the mixture was transferred to a hydrothermal reactor and hydrothermally reacted at 160°C for 4 h. After the reaction was completed, the mixture was centrifuged, washed, and dried to obtain N / Ni-TiO 2 Nanomaterials;
[0038] Step S2: 2 g N / Ni-TiO 2The nanomaterial and 0.1 mL of 1,6-bistrimethoxysilylhexane were added to a mixture containing 80 mL of ethanol and 20 mL of deionized water, stirred and mixed evenly, and ultrasonically dispersed for 30 minutes, and then 10 mL of nano-montmorillonite dispersion was added, and the system temperature was raised to 40°C and stirred for reaction for 3 hours. After the reaction was completed, the modified photocatalyst was obtained. The nano-montmorillonite dispersion was obtained by mixing nano-montmorillonite and deionized water in a dosage ratio of 0.5 g:10 mL and then ultrasonically dispersed for 2 hours.
[0039] Step S3: weigh the raw materials by weight, and stir and mix 12 parts of polyacrylamide, 10 parts of polyethyleneimine, 10 parts of the composite aerogel prepared in Example 1, 5 parts of zeolite, 3 parts of modified photocatalyst and 0.5 parts of sodium hypochlorite to obtain a medical wastewater treatment agent. Embodiment 5
[0040] A method for preparing a medical wastewater treatment agent comprises the following steps:
[0041] Step S1: 0.02 mol urea and 25 mL acetic acid were mixed in a beaker to form a mixed solution 1; 1 mol titanium dioxide was evenly dispersed in 20 mL deionized water, 25 mL of the mixed solution 1 and 0.0075 mol nickel chloride hexahydrate were added and stirred to mix evenly, and finally 20 mL ethanol was added, the temperature was raised to 35°C and ultrasonic treatment was performed for 30 min, and the pH was adjusted to 5, and then the mixture was transferred to a hydrothermal reactor and hydrothermally reacted at 170°C for 6 h. After the reaction was completed, the mixture was centrifuged, washed, and dried to obtain N / Ni-TiO 2 Nanomaterials;
[0042] Step S2: 2.5 g N / Ni-TiO 2 The nanomaterial and 0.4 mL of 1,6-bistrimethoxysilylhexane were added to a mixture containing 80 mL of ethanol and 20 mL of deionized water, stirred and mixed evenly, and ultrasonically dispersed for 30 minutes, and then 10 mL of nano-montmorillonite dispersion was added, and the system temperature was raised to 45°C and stirred for reaction for 4 hours. After the reaction was completed, the modified photocatalyst was obtained. The nano-montmorillonite dispersion was obtained by mixing nano-montmorillonite and deionized water in a dosage ratio of 0.75 g:10 mL and then ultrasonically dispersed for 2 hours.
[0043] Step S3: weigh the raw materials by weight, and stir and mix 16 parts of polyacrylamide, 12 parts of polyethyleneimine, 13 parts of the composite aerogel prepared in Example 2, 7 parts of zeolite, 4 parts of modified photocatalyst and 1 part of sodium hypochlorite to obtain a medical wastewater treatment agent. Embodiment 6
[0044] A method for preparing a medical wastewater treatment agent comprises the following steps:
[0045] Step S1: 0.03 mol urea and 25 mL acetic acid were mixed in a beaker to form a mixed solution 1; 1 mol titanium dioxide was evenly dispersed in 20 mL deionized water, 25 mL of the mixed solution 1 and 0.01 mol nickel chloride hexahydrate were added and stirred to mix evenly, and finally 20 mL ethanol was added, the temperature was raised to 45°C and ultrasonic treatment was performed for 30 min, and the pH was adjusted to 7, and then the mixture was transferred to a hydrothermal reactor and hydrothermally reacted at 180°C for 8 h. After the reaction was completed, the mixture was centrifuged, washed, and dried to obtain N / Ni-TiO 2 Nanomaterials;
[0046] Step S2: 3 g N / Ni-TiO 2 The nanomaterial and 0.8 mL of 1,6-bistrimethoxysilylhexane were added to a mixture containing 80 mL of ethanol and 20 mL of deionized water, stirred and mixed evenly, and ultrasonically dispersed for 30 minutes, and then 10 mL of nano-montmorillonite dispersion was added, and the system temperature was raised to 50°C and stirred for reaction for 5 hours. After the reaction was completed, the modified photocatalyst was obtained. The nano-montmorillonite dispersion was obtained by mixing nano-montmorillonite and deionized water in a dosage ratio of 1 g: 10 mL and then ultrasonically dispersed for 2 hours.
[0047] Step S3: weigh the raw materials by weight, and stir and mix 20 parts of polyacrylamide, 15 parts of polyethyleneimine, 15 parts of the composite aerogel prepared in Example 3, 8 parts of zeolite, 6 parts of modified photocatalyst and 3 parts of sodium hypochlorite to obtain a medical wastewater treatment agent.
[0048] Comparative Example 1
[0049] This comparative example is a wastewater treatment agent, which is prepared by the following steps:
[0050] The raw materials were weighed in parts by weight, and 20 parts of polyacrylamide, 15 parts of polyethyleneimine, 15 parts of silica aerogel, 8 parts of zeolite, 6 parts of the modified photocatalyst prepared in Example 6 and 3 parts of sodium hypochlorite were stirred and mixed uniformly to obtain a medical wastewater treatment agent.
[0051] Comparative Example 2
[0052] The raw materials were weighed in parts by weight, and 20 parts of polyacrylamide, 15 parts of polyethyleneimine, 15 parts of the composite aerogel prepared in Example 3, 8 parts of zeolite, 6 parts of titanium dioxide and 3 parts of sodium hypochlorite were stirred and mixed uniformly to obtain a medical wastewater treatment agent.
[0053] The wastewater treatment agents prepared in Examples 4-6 and Comparative Examples 1-2 were subjected to performance tests: they were added to wastewater at a ratio of 10 g:1 L, treated for 3 h under sunlight and a rotation speed of 150 rpm, left to stand for 30 min, and the upper layer of liquid was taken. The removal rates (%) of phosphorus, COD, formaldehyde, heavy metals, and other harmful particulate matter in the wastewater before and after treatment were tested in accordance with CJ / T 51-2018 "Standard Test Methods for Urban Wastewater Quality". The test results are shown in the following table:
[0054]
[0055] As can be seen from the above table, the wastewater treatment agent prepared by the present invention has a high removal rate for COD, toluene, phosphorus compounds, heavy metal ions and other harmful particulate matter in wastewater. Therefore, it has a good effect in the treatment of medical wastewater.
[0056] The above contents are merely examples and explanations of the concept of the present invention. The technicians in this technical field may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the scope defined by the concept of the invention, they should all fall within the protection scope of the present invention.
Claims
1. A method for preparing a medical wastewater treatment agent, It is characterized in that The following steps are involved: Step S1: urea and acetic acid are mixed in a beaker to form a mixed solution 1; titanium dioxide is then dispersed evenly in deionized water, the mixed solution 1 and nickel chloride hexahydrate are added and stirred to mix evenly, and finally ethanol is added, the temperature is raised to 25-45° C., ultrasonic treatment is performed for 30 minutes, the pH is adjusted to 3-7, and then the mixture is transferred to a hydrothermal reactor, and the mixture is hydrothermally reacted at 160-180° C. for 4-8 hours. After the reaction is completed, the mixture is centrifuged, washed, and dried to obtain N / Ni-TiO 2 Nanomaterials, titanium dioxide, deionized water, mixed solution 1, nickel chloride hexahydrate and ethanol in a ratio of 1 mol: 20 mL: 25 mL: 0.005-0.01 mol: 20 mL, and urea and acetic acid in the mixed solution 1 in a ratio of 0.01-0.03 mol: 25 mL; Step S2: N / Ni-TiO 2 The nanomaterial and 1,6-bistrimethoxysilylhexane were added to a mixture containing ethanol and deionized water and stirred and mixed evenly, and ultrasonically dispersed for 30 minutes, and then the nano-montmorillonite dispersion was added, and the system temperature was raised to 40-50 ° C and stirred for 3-5 hours. After the reaction was completed, the modified photocatalyst N / Ni-TiO 2 The dosage ratio of nanomaterial, 1,6-bistrimethoxysilylhexane, ethanol, deionized water and nano-montmorillonite is 2-3g: 0.1-0.8mL:80mL:20mL:10mL, the nano-montmorillonite dispersion is obtained by mixing nano-montmorillonite and deionized water at a dosage ratio of 0.5-1g:10mL and then ultrasonically dispersing for 2h; Step S3: weighing raw materials by weight, stirring and mixing 12-20 parts of polyacrylamide, 10-15 parts of polyethyleneimine, 10-15 parts of composite aerogel, 5-8 parts of zeolite, 3-6 parts of modified photocatalyst and 0.5-3 parts of sodium hypochlorite to obtain a medical wastewater treatment agent; The composite aerogel is prepared by the following steps: Step A1: dispersing halloysite nanotubes in a mixture of ethanol and deionized water, ultrasonically dispersing for 30 minutes, adding mercaptopropyltrimethoxysilane, and reflux reacting for 18-24 hours under nitrogen conditions. After the reaction is completed, washing and drying are performed to obtain mercaptolated halloysite; Step A2: Add γ-aminopropyltriethoxysilane, 4-trimethoxysilylbutyric acid and ethyl orthosilicate into a flask containing deionized water and stir to mix evenly, then add ammonia water and stir for 8-12 hours. After the reaction is completed, filter, wash and freeze-dry to obtain bifunctional silica; Step A3: Disperse bifunctional silica and chitosan in deionized water, add thiolated halloysite solution, stir and mix for 10 minutes, ultrasonically disperse for 30 minutes, then add gluconolactone solution under vigorous stirring to form a mixed solution, pour the mixed solution into a mold and let stand for 30-50 minutes to form a gel, and then freeze-dry the gel at -60°C for 48 hours to obtain a composite aerogel.
2. A method for preparing a medical wastewater treatment agent according to claim 1, It is characterized in that In step A1, the usage ratio of halloysite nanotubes, ethanol, deionized water and mercaptopropyltrimethoxysilane is 1-2 g: 90 mL: 10 mL: 1.2-2.2 g.
3. A method for preparing a medical wastewater treatment agent according to claim 1, It is characterized in that In step A2, the usage ratio of γ-aminopropyltriethoxysilane, 4-trimethoxysilylbutyric acid, ethyl orthosilicate, deionized water and ammonia water is 0.01-0.02 mol: 0.005-0.015 mol: 0.02 mol: 100 mL: 0.1-0.16 mL.
4. A method for preparing a medical wastewater treatment agent according to claim 1, It is characterized in that In step A3, the dosage ratio of bifunctional silica, chitosan, deionized water, thiolated halloysite solution and gluconolactone solution is 0.2-0.5 g: 0.5-0.9 g: 50 mL: 10 mL: 10 mL.
5. A method for preparing a medical wastewater treatment agent according to claim 1, It is characterized in that In step A3, the thiolated halloysite solution is prepared by mixing thiolated halloysite and deionized water in a ratio of 0.05-0.09 g:10 mL, and the gluconolactone solution is prepared by mixing gluconolactone and deionized water in a ratio of 0.3-0.6 g:10 mL.
